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Abstract  
Several parameters of immune function, oxidative and inflammatory stresses have been 
proposed as markers of health and predictors of longevity and mortality. However, it is 
unknown if any of these parameters can be predictive of survival in centenarians. 
Therefore, in a group of 27 centenarians, at the time of admission to the Clinical Hospital 
of Madrid, a series of immune function, antioxidant, oxidant and inflammatory 
parameters, were studied. Some centenarians survived and others did not, establishing 
two groups, "survivors" (n = 9) and "non-survivors" (n = 18). The results show that 
surviving centenarians display higher neutrophil chemotaxis and microbicidal capacity, 
NK activity, lymphoproliferation, glutathione reductase activity and basal IL-10 release. 
Moreover, they show lower neutrophil and lymphocyte adherence, superoxide anion and 
malondialdehyde concentrations and basal release of TNF-α. The ODDS RATIOS (OR) 
for survival for these parameters were also calculated and those with the highest ORs 
were the lymphoproliferative capacity and the ex vivo basal and stimulated release of IL-
6 from mononuclear cells (OR = 136.00). Therefore, these parameters have the potential 
to be used in the clinical setting as predictors of survival in centenarians. In the survivors 
group, the same parameters were also analyzed after three months. Since survivors 
showed an increase in neutrophil and lymphocyte chemotaxis capacity during the 
recovery period, reaching similar values to those observed in healthy centenarians, these 
could be proposed as indicators of recovery.  
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INTRODUCTION 
Centenarians have been described as the best example of successful aging, given that they 
largely avoided the age-related diseases responsible for the high morbidity and mortality 
of aging [1]. Thus, these individuals not only escape the typical infections of the elderly, 
but also show a peculiar resistance against most common age-related diseases through 
life, such as cancer, cardiovascular disease, dementia, diabetes and cataracts [2-4]. 
Consequently, in these individuals, morbidity is compressed toward the end of life (that 
is, health span approximates to life span) and then, there is a rapid onset of decline in the 
functional state which usually ends up in hospitalization and death. In fact, certain studies 
have shown high rates of disability (around 90%) among centenarians [5]. However, 
given that over the last decades there were not many centenarians, knowledge of 
evidence-based health care in centenarians is still poor [6]. 
Nevertheless, given that the number of centenarians is projected to rise rapidly over the 
next few years [7,8], there is an urgent need to identify prognosis markers of outcome in 
this extreme long-lived group, due to the increasing evidence suggesting the different 
significance of health indicators in centenarians with respect to younger seniors [9, 10]. 
As such, traditional metabolic indices like glucose, triglycerides, cholesterol and 
creatinine levels have been found to be limited as prognostic markers in centenarians [9, 
11]. Moreover, whereas high systolic blood pressure in adulthood is associated with an 
early mortality, in centenarians it has been found to be a strong predictor of survival for 
at least one year [9]. In the same study, higher survival probability was associated with 
lower white blood counts and lower levels of inflammatory mediators in plasma, such as 
CRP and IL-6. Despite the fact that these studies were carried out in healthy centenarians, 
in which the health status was not endangered, it seems feasible that function parameters 
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of immune cells as well as inflammatory mediators could have the potential to be used as 
predictors of survival after hospital admission.   
As a matter of fact, the functional capacity of the immune system, an essential 
homeostatic system, has been widely proposed to be a good marker of health and predictor 
of longevity [12, 13] and certain immune markers have been identified to predict survival 
in people between 60 and 80 years of age [14-16]. In addition, among the most 
investigated markers as predictors of health outcomes, inflammatory markers stand out. 
In this context, a high pro-inflammatory state has been shown to be predictive of mortality 
in the elderly [17-22]. However, with respect to centenarians, the association between 
pro-inflammatory markers and mortality is not so clear. Some studies have found an 
association between pro-inflammatory cytokines such as TNF-α and dementia and 
mortality in centenarians [23, 24] whereas other centenarians in spite of displaying large 
amounts of pro-inflammatory cytokines exhibit a good clinical condition. This latter fact 
has led researchers to consider the idea that the observed pro-inflammatory state in 
centenarians could be an adaptive mechanism, and as such it should not be considered as 
a risk factor [25]. Additionally, oxidative stress markers have also received much 
attention as prognosis markers and certain redox markers have been shown to be 
predictive of mortality in elderly people [26-28]. However, and despite the usefulness of 
all the above mentioned parameters as predictors of mortality in elderly populations, their 
prognostic role in centenarians has scarcely been investigated. 
Hence, the aim of the study was to investigate if a series of parameters of immune 
function, redox and inflammatory stresses in hospitalized centenarians have the potential 
to be used to predict survival. For this purpose, several immune function (adherence and 
chemotaxis of neutrophils and lymphocytes, phagocytosis and microbicidal capacity of 
neutrophils, Natural Killer cytotoxic activity, proliferative and cytokine release of IL-1β, 
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IL-6, TNF-α and IL-10 from mononuclear cells in response to a mitogen) redox 
(antioxidant glutathione peroxidase and reductase activities, reduced glutathione, 
oxidized glutathione, intracellular anion superoxide and malondialdehyde 
concentrations) and inflammatory stress parameters (basal release of the above mentioned 
cytokines) were analyzed in a group of centenarians (N=27) at the moment of hospital 
admission. These parameters were afterwards related to centenarian´s survival or 
mortality to identify those markers with the highest predictive power. In addition, in the 
survivors group, the same parameters were analyzed after three months, to find out which 
markers could serve as indicators of recovery. 
METHODS 
Subjects and extraction of blood samples 
Twenty-seven centenarians were recruited for this study and peripheral blood was 
extracted at the moment of admission to the Geriatric Service of the Hospital Clínico San 
Carlos in Madrid, Spain. They were divided into two groups, those who survived after 
admission, which will be referred to as “Survivors” (N=9) and those who did not survive, 
“Non-survivors” (N=18). Peripheral blood samples (10 mL) were collected in the 
morning, to avoid circadian changes in immune function parameters, using venipuncture 
and placed into sodium citrate-buffered Vacutainer tubes (BD Diagnostics – Preanalitical 
Systems, Madrid, Spain). Peripheral blood was also extracted from the centenarians of 
the survivors group after 3 months. Moreover, another group of “healthy centenarians” 
(N=10), who were not hospitalized during the previous year and retained certain activities 
of daily living (ADL) such as bathing, dental hygiene, toileting, eating, dressing, transfer 
and mobility, was also recruited and used as the control group. This study was performed 
with the informed consent of the donors and was approved by the Hospital Clínico San 
Carlos Ethics Committee. 
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Analysis of immune function parameters 
Isolation of neutrophils and lymphocytes. Both polymorphonuclear (PMNs, mainly 
neutrophils) and mononuclear (mainly lymphocytes) leukocytes were isolated from 
whole blood following a previously described method [12], using 1.119 and 1.077 density 
Hystopaque (Sigma-Aldrich, Spain) for neutrophil and lymphocyte separation, 
respectively. Collected cells (95% of viability determined using trypan blue staining) 
were adjusted to the corresponding final concentrations for the development of each 
assay. 
Adherence. Briefly, 1mL of whole blood (diluted 1:1 with Hank’s medium) was placed 
in a Pasteur pipette into which 50 mg of nylon fiber was packed to a length of 1.25 cm. 
After 10 minutes, the effluent had drained by gravity. The adherence index (AI) 
percentage was calculated as follows: 
AI = 
𝐶𝑒𝑙𝑙𝑠
𝑚𝑙
𝑖𝑛𝑖𝑡𝑖𝑎𝑙−
𝐶𝑒𝑙𝑙𝑠
𝑚𝑙
𝑒𝑓𝑓𝑙𝑢𝑒𝑛𝑡
𝐶𝑒𝑙𝑙𝑠
𝑚𝑙
𝑖𝑛𝑖𝑡𝑖𝑎𝑙
 𝑥 100 
Chemotaxis. Cell suspensions were adjusted to 0.5 x 106 cells (neutrophils or 
lymphocytes)/ml in Hank's medium and placed into a Boyden chamber. The number of 
cells that migrated towards formyl-Met-Leu-Phe (10-8 M) after 3 hours of incubation were 
counted and expressed as the Chemotaxis Index, as previously described [12]. 
Phagocytosis. Cell suspensions were adjusted to 0.5 x 106 neutrophils/ml in Hank´s 
medium and placed into migration inhibition factor (MIF) plates for 30 min at 37ºC to 
allow neutrophils to attach to the plastic forming a monolayer of cells. After washing, 
polystyrene latex beads (1.1 μm mean particle size) (LB11, Sigma-Aldrich) diluted to 1% 
were added to the plates. After 30 min of incubation at 37ºC, the number of beads ingested 
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by 100 neutrophils was counted and expressed as the Phagocytic Index, as previously 
described [12]. 
Intracellular superoxide anion and microbicidal capacity. Cell suspensions were 
adjusted to 106 neutrophils/ml in Hank´s medium and mixed with Nitro Blue Tetrazolium 
(NBT: 1 mg/ ml) and with Hank's solution (basal conditions) or latex beads (stimulated 
conditions). After 60 min of incubation at 37 °C the intracellular reduced NBT was 
extracted with dioxin (Sigma-Aldrich) and absorbance was determined at 525 nm in a 
spectrophotometer. In addition, the percentage of superoxide anion stimulation in 
response to latex beads, understood as microbicidal capacity, was calculated with non-
stimulated values being 100%. 
Natural killer cytotoxicity. Cell suspensions were adjusted to 106 lymphocytes/ml in 
RPMI 1640 medium and placed into 96-well plates. Human K-562 lymphoma cells were 
added into the wells. The ratio effector/target was 10/1. These cells were cultured for 4 
hours. Natural killer activity was assessed by quantifying released lactate dehydrogenase 
into the medium (Cytotox 96 TM Promega, Germany). The results were expressed as the 
percentage of tumor cells killed (% lysis), as previously described [12]. 
Lymphoproliferative capacity. Cell suspensions were adjusted to 0.5 x 106 
lymphocytes/ml in RPMI 1640 supplemented with fetal bovine serum and placed into 96-
well plates. The mitogen Phytohemagglutinin (PHA) (1 µg/mL per well) or complete 
medium were added into wells and incubated for 48h. After this incubation, supernatants 
were obtained for cytokine quantification. Then, 3H-thymidine was added together with 
complete medium and incubated for 24h. 3H-thymidine uptake was quantified in a beta 
counter both in basal and stimulated conditions and results were expressed as 
lymphoproliferation capacity (%), 100% being the counts per minute (cpm) in basal 
conditions, as previously described [12]. 
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Cytokine measurement. Basal and PHA-stimulated release of IL-1β, IL-6, TNF-α and 
IL-10 was measured simultaneously in supernatants from mononuclear cells by multiplex 
luminometry after 48-hours incubation (Beadlyte mouse multiplex cytokine detection 
system, HSTCMAG-28SK-05, Deltaclon, Spain).  
Determination of redox parameters 
Whole blood cells. Whole blood cells (including erythrocytes and total leukocytes) were 
obtained as previously described [10]. Aliquots of peripheral blood were diluted 1:1 in 
RPMI 1640 (Gibco, Canada) and were incubated for 4 h at 37ºC in a saturated atmosphere 
of humidity and CO2. After centrifuging at 900g for 10 min, plasma was removed and the 
whole blood cells were stored at -80ºC until used. 
Glutathione peroxidase activity. Each sample of whole blood cells was re-suspended in 
oxygen-free phosphate buffer (pH 7.4 50 mM). Then, it was sonicated and the supernatant 
(1:30) was used for the enzymatic reaction together with cumene hydroperoxide as a 
substrate (cumene-OOH) as previously described [10]. Oxidation of NADPH was 
measured at 340 nm. The results were expressed as units (U) of glutathione peroxidase 
activity/mg protein. 
Glutathione reductase activity. The samples of whole blood cells were re-suspended in 
oxygen-free phosphate buffer (pH 7.4 50 mM). Then, they were sonicated and 
supernatants (1:5) were used for the enzymatic reaction together with GSSG 80 mM as 
substrate, as previously described [10]. Oxidation of NADPH was measured at 340 nm. 
The results were expressed as units (U) of glutathione reductase activity/mg protein. 
Glutathione concentration. Whole blood cells were re-suspended in phosphate buffer 
(pH 8 50 mM EDTA 0.1 M). Then, they were sonicated and supernatants were used for 
the quantification of both reduced (GSH) and oxidized (GSSG) glutathione by the 
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reaction capacity that GSSG and GSH have with o-phthalaldehyde (OPT) at pH 12 and 
pH 8, respectively, resulting in the formation of a fluorescent compound measured at 420 
nm, as previously described [10]. Results were expressed as nmol of GSSG and GSH per 
milligram of protein. Moreover, the GSSG/GSH ratio was calculated for each sample. 
Malondialdehyde (MDA) concentration. Quantification of malondialdehyde (MDA) 
was achieved using the commercial kit “Lipid peroxidation (MDA) Assay Kit” 
(Biovision, USA). Whole blood cells were re-suspended in 300 μl MDA lysis buffer 
containing 0.1mM Butylated Hydroxytoluene (BHT), sonicated and centrifuged at 
13000g for 10 min. Supernatants were collected, mixed with thiobarbituric acid (TBA) 
and incubated in a water bath at 95°C for 60 min. Then, samples were centrifuged, 
supernatants collected and absorbance was measured at 532 nm, as previously described 
[10]. Results were expressed as nmol MDA/mg protein. 
Statistical Analysis 
Normality of the samples was checked by the Levene test. Differences between groups 
were studied using Student´s T test for independent samples. Differences in the survivor 
group at the moment of hospital admission and after three months were studied using 
Student´s T test for dependent samples. In addition, all investigated parameters were 
stratified into two groups to be analyzed as categorical variables. Cut-off values were 
chosen to maximize differences between groups. Thus, the cut-off value was established 
using the lowest or highest value (depending on the parameter) that differentiated the 
most between survivors and non survivors. Afterwards, these categorical variables were 
used to estimate the odds ratios (ORs), 95% confidence intervals (CIs) and Pearson Chi-
Square test in logistic regression models. Two-sided P<0.05 was considered the minimum 
level of significance in all cases. 
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RESULTS 
The main characteristics of centenarians subdivided into “Survivors” and “Non 
Survivors” are reported in Table 1. There was the same proportion of men and women in 
each group and no differences were found between survivors and non-survivors regarding 
age, cause of admission or biochemical parameters. 
The results regarding immune functionality are shown in Figure 1. The group of survivors 
showed, at the moment of admission, in comparison with the group of centenarians that 
died within the next three months, higher values of neutrophil chemotaxis (P < 0.05), 
Natural Killer cytotoxicity (P < 0.001), microbicidal capacity of neutrophils (P < 0.001) 
and percentage of lymphoproliferation in response to PHA (P < 0.001). Moreover, this 
group showed lower adherence of neutrophils (P < 0.001) and lymphocytes (P < 0.01). In 
addition, in response to PHA, centenarian survivors released more IL-1β (P < 0.01) and 
IL-6 (P < 0.001) than the non survivors. No differences were found in these parameters 
between those patients whose had an infection (black circles and squares) and those who 
did not (white circles and squares). 
With respect to the redox and inflammatory state of these patients (Figure 2), no 
differences were found between survivors and non-survivors regarding oxidized 
glutathione (GSSG) (1.07±0.35; 0.96±0.23; nmol/mg protein, respectively) and reduced 
glutathione (GSH) (1.43±0.63; 1.66±0.74; nmol/mg protein, respectively) concentrations 
nor in GSSG/GSH ratios (0.74±0.42; 0.56±0.26) in whole blood. Nevertheless, the group 
of survivors displayed, at the moment of admission, higher glutathione reductase activity 
(P < 0.01) and lower MDA concentration in whole blood (P < 0.05) as well as lower 
neutrophil concentration of intracellular superoxide anion (P < 0.001), compared to non-
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survivors. With respect to the inflammatory parameters, the group of survivors displayed 
higher IL-6 and IL-10 and lower TNF-α release in basal conditions (P < 0.001) than the 
non-survivors. 
In particular, the probability of survival within three months after hospital admission 
significantly increased with the increasing parameters shown in Table 2. These are: 
neutrophil chemotaxis (> 170 Chemotaxis Index, OR 7.00) and microbicidal activity (> 
190%, OR 64.00), Natural Killer activity (> 77%, OR 34.00), PHA-stimulated 
lymphoproliferation (> 242%, OR 136.00), basal release of IL-6 (> 950 pg/mL, OR 
136.00) and IL-10 (> 700 pg/mL, OR 59.50), PHA-stimulated release of IL-1β (> 1500 
pg/mL, OR 7.00) and IL-6 (> 850 pg/mL, OR 136.00) and glutathione reductase activity 
(> 248 U GR/mg protein, OR 40.00). On the contrary, the probability of survival within 
three months after hospital admission also significantly increased with decreasing 
neutrophil adherence (> 33%, OR 0.017), lymphocyte adherence (> 36%, OR 0.250), 
basal release of TNF-α (> 202 pg/mL, OR 0.036), intracellular superoxide anion (> 43 
nmol NBT/mg protein, OR 0.007) and MDA (> 3.19 nmol MDA/mg protein, OR 0.036) 
concentration, as indicated in Table 2. 
Moreover, changes in the parameters analyzed were also investigated in the survivors 
group after the recovery period. It was found that after three months, survivors showed 
an increase in neutrophil and lymphocyte chemotaxis (P < 0.05; P < 0.01, respectively), 
phagocytic index (P < 0.01) and glutathione peroxidase activity (P < 0.01) as shown in 
Table 3, whereas all the other parameters studied remained unchanged. However, in order 
to ascertain the significance of these parameters as markers of recovery they were further 
compared with a group of healthy centenarians, who were not hospitalized during the 
previous year. The results show that whereas neutrophil and lymphocyte chemotaxis 
parameters in centenarians, after three months of recovery, reached similar values to those 
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observed in healthy centenarians, the phagocytic index was still lower after the recovery 
period than in healthy centenarians (P < 0.05).  Moreover, glutathione peroxidase activity 
was higher in centenarians after the recovery period than in healthy centenarians (P < 
0.01). 
 
DISCUSSION 
Survival over 100 years of age used to be an extraordinary occurrence. However, over the 
past decades, the world population of the oldest inhabitants is growing rapidly [8, 29]. Up 
until 1990, there were only 100000 centenarians, which increased to nearly half a million 
by 2015. Moreover, the 2017 Revision of World Population Prospects from the United 
Nations forecasted that there will be 3.7 million centenarians worldwide by 2050. 
Consequently, finding prognostic markers in centenarians is an urgent need given that 
they will allow clinicians and clinical investigators to identify groups at lower and higher 
risk for mortality and consequently, to choose the most appropriate treatment strategies 
[30, 31].  
Even though several studies have found some immune function parameters as predictors 
of mortality in elderly individuals [14-16, 32, 33], to the best of our knowledge, this is 
the first study in which immune cell function parameters have been investigated as 
predictive of mortality in centenarians upon hospital admission. It was demonstrated that 
those centenarians that survived showed a better immune function, evidenced by a lower 
adherence of neutrophil and lymphocytes, higher neutrophil chemotaxis and microbicidal 
capacity, higher Natural Killer cytotoxic activity and higher lymphoproliferation in 
response to the mitogen PHA at the moment of hospital admission compared to those who 
did not survive. With respect to the release of cytokines by mononuclear cells after 
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stimulation, centenarian survivors displayed higher IL-1β and IL-6 cytokine release 
compared to the non-survivor group, which agrees with a previous study in which healthy 
centenarians were found to produce the most IL-1β and TNF-α after stimulation, 
compared to unhealthy ones [34]. Another study also demonstrated that 85 years-old 
human subjects who produce low TNF-α after a stimulus, have a more than two-fold 
increased mortality risk compared to peers with a higher release [35].  
It is also important to recall that centenarians, in addition to displaying an excellent 
immune profile [12, 36, 37], also show a better redox profile than aged subjects. In a 
recent study, it was demonstrated that healthy centenarians exhibit a unique redox 
signature, characterized by low levels of oxidant parameters and very high antioxidant 
enzymatic activities, in comparison to individuals of other ages [10]. In the present study, 
those centenarians that survived also displayed lower oxidative stress levels, evidenced 
by a higher glutathione reductase activity and lower intracellular superoxide anion and 
MDA concentrations at the moment of hospital admission, in comparison to those 
centenarians that died. These results agree with a previous study carried out on 
centenarians in which those who had the best physical functional capacity also had the 
highest glutathione reductase activity [38].  
Moreover, we attempted to establish some reference values for the investigated 
parameters in centenarians creating two groups, those that were above the cut-off value 
and those that were below. The probability of survival was then calculated using the Odds 
ratio (OR), and it was found that the probability of survival within three months after 
hospital admission significantly increased with increasing neutrophil chemotaxis, Natural 
Killer activity, basal release of IL-6, PHA-stimulated lymphoproliferation and release of 
IL-1β and IL-6 and glutathione reductase activity.  However, the probability of survival 
increased with decreasing neutrophil adherence, basal release of TNF-α, intracellular 
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superoxide anion and MDA concentrations. Interestingly, those with the highest OR were 
the lymphoproliferative capacity in response to PHA and the basal and PHA-stimulated 
release of IL-6. The proliferative capacity of lymphocytes has also been found to be 
predictive of mortality in elderly populations. In fact, this parameter has been used to 
ascertain the Immune Risk Phenotype in elderly people, which relates to mortality [16, 
39]. In addition, with respect to the basal and stimulated release of IL-6, the results are 
surprising given that this cytokine has been generally viewed as pro-inflammatory and 
consequently, harmful. However, the results from the present study indicate that those 
centenarian who, upon hospital admission, show a higher release of IL-6 have a higher 
probability of survival. Thus, it could be that this cytokine may be playing an essential 
role regulating and orchestrating other cells. Accordingly, a recent study has unravelled 
a new role of IL-6 in mediating the reprogramming of cells associated with senescence 
[40], which could reverse the age-associated silencing of important antioxidant and anti-
inflammatory genes. In addition, these results agree with a longitudinal study carried out 
on mice [41] in which it was found that those mice that at the very old age had a higher 
basal release of IL-6, were the ones that reached longevity later on.  
The potential value of the parameters studied as indicators of recovery was also 
investigated by measuring them in the surviving centenarians after a period of three-
months. It was found that most of the parameters analyzed did not change within this time 
frame, but neutrophil and lymphocyte chemotaxis, phagocytic capacity and glutathione 
peroxidase activity were found to increase in these subjects during the recovery period. 
In fact, neutrophil and lymphocyte chemotaxis parameters reached similar levels to those 
observed in healthy centenarians, and because of that, they could be used as recovery 
indicators. However, phagocytic capacity was still found to be lower whereas glutathione 
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peroxidase was higher after the recovery period than in healthy centenarians. Therefore, 
it seems that these last markers require more recovery time to reach healthy values. 
In summary, the results of the present study demonstrate that there is a link between a 
better functional capacity of immune cells and a higher chance of survival after hospital 
admission in centenarians. It is known that the immune system does not work alone but 
in close connection with the other regulatory systems, such as the nervous and the 
endocrine systems, forming the so-called neuro-immuno-endocrine communication, 
responsible for the maintenance of homeostasis of an individual [42]. Thus, a better 
functional capacity of immune cells reflects a better functioning of the neuro-immuno-
endocrine system, as a whole, which is capable of adapting and restoring homeostasis 
after challenging situations, such as those causing hospital admission. Moreover, some 
reference cut-off values for specific markers have been provided, such as neutrophil 
adherence, chemotaxis and microbicidal activity, Natural Killer activity, PHA-stimulated 
lymphoproliferation, basal release of IL-6, TNF-α and IL-10; PHA-stimulated release of 
IL-1β and IL-6, glutathione reductase, intracellular superoxide anion and MDA 
concentrations. Thus, the combination of some of these parameters has the potential to be 
used in the clinical setting to evaluate the risk of mortality in centenarians. Nevertheless, 
it needs to be investigated if proposed reference values for the parameters studied are 
valid for other centenarian populations, as well as if they may need to be adjusted 
depending on the laboratory performance techniques. It is important to remark that these 
OR were obtained in a centenarian population. Thus, and although some immune 
function, oxidative and inflammatory parameters have been shown to be predictive of 
survival in the elderly, the ones reported here should also be investigated at other ages. In 
fact, in a previously published study from our research group carried out on mice, it was 
demonstrated that whereas some immune function/inflammatory and oxidative stress 
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parameters are predictive of mortality across aging, some others are specific to an age 
group [41]. Thus, the validation of the predictive capacity of these parameters in younger 
populations should be performed. 
An important limitation of the study is that the functional and cognitive status of 
hospitalized centenarians was not evaluated. In the same way, the clinical history of these 
patients was not taken into account. Nevertheless, these factors may have influenced the 
final outcome and should be included and investigated in future studies.  
A strength of the study is that some of the investigated markers were found to have a high 
OR for survival, even though our study sample represented a very heterogeneous group 
of subjects, with several different causes of admission.  However, given that data were 
analyzed retrospectively, future prospective studies are needed to confirm the predictive 
validity of these markers in a larger sample. Nevertheless, given that the number of 
extremely old individuals is rapidly increasing worldwide, the health state of centenarians 
as well as the identification of markers for its evaluation are important issues of public 
health. Accordingly, the results of the present study, although preliminary, highlight the 
potential usefulness of immune function and oxidative-inflammatory stress markers in 
predicting short-term survival after hospital admission in centenarians and provide a 
novel benchmark for future work aimed at establishing mortality risk indices in this 
population. 
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Table 1. Cause of admission, biochemical and demographic characteristics of 
centenarians included in the study. 
 Survivors Non Survivors 
N 9 18 
Age 99.44 ± 0.88 100.47 ± 1.81 
Men/Women (%) 33.33 % 29.41 % 
Brain Ischemia (%) 66.66 % 50.00 % 
Upper Respiratory 
Infection (%) 
55.55 % 55.55 % 
Urinary Infection (%) 22.22 % 33.33 % 
Bone Fracture (%) 11.11 % 11.11 % 
Anemia (%) 22.22 % 11.11 % 
Constipation (%) 11.11 % 27.77 % 
Kidney Failure (%) 22.22 % 33.33 % 
Confusional State (%) 33.33 % 33.33 % 
Average number causes of 
admission per patient 
3.00 3.39 
Systolic Blood Pressure 
(mmHg) 
131.22 ± 10.42 126.61 ± 25.37 
Glucose (mg/dL) 161.33 ± 92.84 134.68 ± 65.09 
Creatinine (mg/dL) 1.30 ± 0.34 1.33 ± 0.66 
Cholesterol (mg/dL) 150.37 ± 25.33 142.26 ± 33.11 
Triglycerides (mg/dL) 72.83 ± 13.48 103.92 ± 31.28 
Uric Acid (mg/dL) 8.24 ± 2.26 6.05 ± 3.02 
Causes of admission are shown as percentages whereas age and biochemical data are 
expressed as the mean ± standard deviation of the values in each group. Because 
hospitalized individuals had more than one cause of admission, average number of causes 
per patient in each group is also shown. 
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Table 2. Predictor parameters of survival within three months after hospital 
admission. 
 Cut-off value Odds 
ratio 
95% 
Confidence 
Interval 
P-value 
Neutrophil Chemotaxis > 170 C. Index 7.00 1.19 – 41.36 P < 0.05  
Natural Killer activity > 77 % 34.00 2.94 – 392.85 P < 0.001  
Microbicidal activity > 190 % 64.00 5.02 – 816.44 P < 0.001  
PHA-lymphoproliferation > 242 % 136.00 7.51 – 2462.77 P < 0.001  
Basal release of IL-6 > 950 pg/mL 136.00 7.51 – 2462.77 P < 0.001  
Basal release of IL-10 > 700 pg/mL 59.50 4.62 – 767.18 P < 0.001 
PHA-induced release of IL-
1β 
> 1500 pg/mL 7.00 1.19 – 41.36 P < 0.05  
PHA-induced release of IL-6 > 850 pg/mL 136.00 7.51 – 1462.77 P < 0.001 
Glutathione reductase  > 248 U/mg protein 40.00 3.56 – 450.00 P < 0.001 
     
Neutrophil adherence > 33 % 0.0017 0.001 – 0.217 P < 0.001  
Lymphocyte adherence > 36 % 0.250 0.046 – 1.365 P = 0.100 
Basal release of TNF-α > 202 pg/mL 0.036 0.003 – 0.377 P < 0.001  
Intracellular superoxide 
anion concentration 
> 43 nmol NBT/mg 
protein 
0.007 0.000 -0.133 P < 0.001  
Malondialdehyde 
concentration 
> 3.19 nmol 
MDA/mg protein 
0.036 0.003 – 0.377 P < 0.001  
Cut-off values were established using the lowest or highest value (depending on the 
parameter) that differentiated the most between survivors or non survivors. The Odds 
ratios were calculated by dividing the probability of survival by that of dying. 
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Table 3. Immune and Redox parameters that changed during the 3 months-period 
of recovery in those centenarians that survived hospitalization. Comparison with 
previous data from a group of healthy centenarians. 
 
 
 Survivors at 
the moment of 
admission 
Survivors after 
3 months 
period 
P-value Healthy 
Centenarians 
P-value 
Neutrophil 
Chemotaxis 
201.22 ± 81.33 295.44 ± 57.59 P < 0.05 439.20 ± 231.79 P = 0.240 
Lymphocyte 
Chemotaxis 
258.11 ± 50.09 442.00 ± 184.01 P < 0.01 417.90 ± 148.23 P = 0.802 
Phagocytic 
Index 
194.67 ± 33.74 303.67 ± 74.43 P < 0.01 870.30 ± 288.21 P < 0.05 
GPx activity 263.96 ± 112.55 487.94 ± 148.79 P < 0.01 227.74 ± 72.35 P < 0.01 
Differences within individuals at the moment of admission and after 3 months were 
analyzed using the Student´s T test for dependent samples. The differences between the 
recovered and healthy centenarians were evaluated using Student´s T test for independent 
samples. *: P < 0.05; **: P < 0.01; ***: P < 0.001. 
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FIGURE LEGENDS 
 
Figure 1. Immune function parameters in surviving and non-surviving centenarians upon 
hospital admission. A) Neutrophil Adherence (%); B) Lymphocyte Adherence (%), C) 
Neutrophil Chemotaxis (Chemotaxis Index); D) Lymphocyte Chemotaxis (Chemotaxis 
Index); E) Phagocytic Index; F) Natural Killer Cytotoxicity; G) Microbicidal Activity; H) 
PHA-Induced Proliferation; I) PHA-stimulated IL-1β; J) PHA-stimulated IL-6; K) PHA-
stimulated TNF-α; L) PHA-stimulated IL-10. *: P < 0.05; **: P < 0.01; ***: P < 0.001 between 
survivors and non survivors. Black circles and squares indicate patients suffering from infection 
either respiratory or urinary. 
 
Figure 2. Redox and inflammatory parameters in surviving and non-surviving centenarians 
upon hospital admission. A) Glutathione Peroxidase activity; B) Glutathione Reductase 
activity; C) Basal Intracellular Superoxide anion and D) Malondialdehyde concentration; 
E) Unstimulated IL-1β; F) Unstimulated IL-6; G) Unstimulated TNF-α; H) Unstimulated 
IL-10. *: P < 0.05; **: P < 0.01; ***: P < 0.001 between survivors and non survivors. Black 
circles and squares indicate patients suffering from infection either respiratory or urinary. 
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Figure 1 
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Figure 2 
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